New agents for Gram-positive bacteria
Related Experiment Video
Updated: Oct 11, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
1Clinical Pharmacokinetics Laboratory, Kaleida Health/Millard Fillmore Hospital and School of Pharmacy, State University of New York-Buffalo, NY, USA.
Abstract:
Infections caused by multiple-resistant Gram-positive organisms continue to occur at an alarming rate worldwide. Two new and unique antimicrobial agents targeted specifically against such organisms, quinupristin/dalfopristin and linezolid, have been approved for use in the USA in the past year and will play an important role in the treatment of life-threatening infections. In addition, several new fluoroquinolones have been approved recently or will be available in the near future to aid in the treatment of infections caused by resistant strains of Streptococcus pneumoniae.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Gram-negative Bacterial Protein Secretion Systems
Bacterial Phylum Actinobacteria
Antibiotic Selection
Production of Antibiotics
Bacterial Phylum Proteobacteria

